act-709478
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2017 (NCT03165097)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- act-709478
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04123288 | Phase 1 | Oct 31, 2019 | Idorsia Pharmaceuticals Ltd. |
| NCT03239691 | Phase 2 | Oct 6, 2017 | Idorsia Pharmaceuticals Ltd. |
| NCT03165097 | Phase 1 | Jun 30, 2017 | Actelion |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Idorsia Pharmaceuticals Ltd. | For profit | 2 | 2 | 2 | 2017 |
| Actelion | For profit | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1